Scientific Advisory Board

The members of the Celator Scientific Advisory Board are recognized world leaders in cancer research, clinical oncology and drug development.

Alan Sartorelli (Chairman), Ph.D., Alfred Gilman Professor of Pharmacology, Yale University (New Haven, CT)

Emil Frei III (Emeritus), MD, Physician-in-Chief, Dana-Farber Cancer Institute (Boston, MA)

Frederick Appelbaum, MD, Director of Clinical Research, Fred Hutchinson Cancer Research Center (Seattle, WA)

Joseph Bertino, MD, The Interim Director of Robert Wood Johnson Medical School's Cancer Institute of New Jersey (New Brunswick, NJ)

Stephen Carter, MD, Former Senior VP, Worldwide Clinical R&D, Bristol-Myers Squibb (New York, NY)

Edward Chu, MD, Chief of Medical Oncology, Yale Cancer Center, Professor of Medicine and Pharmacology, Yale University (New Haven, CT)

Ross Donehower, MD, Director, Division of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center of Johns Hopkins (Baltimore, MD)

John Lazo, Ph.D., Allegheny Foundation Professor, Dept. of Pharmacology, University of Pittsburgh (Pittsburgh, PA)